Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinomain vitroandin vivo

Proton therapy for hepatocellular carcinoma

(2013) Ted C. Ling et al.   Chinese Journal of Cancer Research

Expression of CXCL14 and its anticancer role in breast cancer

(2012) Xiao-Li Gu et al.   BREAST CANCER RESEARCH AND TREATMENT

Rb inactivation in cell cycle and cancer: The puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase

(2011) Sabine Paternot et al.   CELL CYCLE

Interventional Radiological Treatment of Hepatocellular Carcinoma: An Update

(2011) Anurag Shrimal et al.   Indian Journal of Surgery

An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population

(2011) Xing Gu et al.   MOLECULAR BIOLOGY REPORTS

Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine

(2010) Reika Komori et al.   BIOMEDICAL RESEARCH-TOKYO

Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells

(2010) Eun Young Song et al.   CANCER RESEARCH

Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells

(2010) Yojiro Maehata et al.   FREE RADICAL RESEARCH

Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis

(2010) M Tessema et al.   ONCOGENE

Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism

(2009) H. Pelicano et al.   CANCER RESEARCH

Hepatocellular carcinoma in the Asia pacific region

(2009) Man-Fung Yuen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth

(2009) M. Augsten et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumour-immune cell interactions modulated by chemokines

(2008) Karin Jöhrer et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY

CXCL14 expression and potential function in pancreatic cancer

(2007) Moritz N. Wente et al.   CANCER LETTERS